Washington Trust’s Charles River Laboratories CRL Stock Holding History

Washington Trust’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-528	Closed	-$79.5K	–	350
2025 Q1	$79.5K	Hold	528	–	–	﹤0.01%	351
2024 Q4	$97.5K	Sell	528 -1	-0.2%	-$193	﹤0.01%	343
2024 Q3	$104K	Buy	529 +2	+0.4%	+$416	﹤0.01%	348
2024 Q2	$109K	Buy	527 +4	+0.8%	+$906	﹤0.01%	338
2024 Q1	$142K	Sell	523 -1	-0.2%	-$239	0.01%	305
2023 Q4	$124K	Buy	524 +24	+5%	+$4.72K	﹤0.01%	307
2023 Q3	$98K	Hold	500	–	–	﹤0.01%	309
2023 Q2	$105K	Hold	500	–	–	﹤0.01%	315
2023 Q1	$101K	Hold	500	–	–	﹤0.01%	320
2022 Q4	$109K	Hold	500	–	–	0.01%	302
2022 Q3	$98K	Hold	500	–	–	﹤0.01%	302
2022 Q2	$107K	Hold	500	–	–	0.01%	300
2022 Q1	$142K	Hold	500	–	–	0.01%	295
2021 Q4	$188K	Hold	500	–	–	0.01%	270
2021 Q3	$206K	Hold	500	–	–	0.01%	311
2021 Q2	$185K	Sell	500 -130	-21%	-$43.4K	0.01%	318
2021 Q1	$183K	Buy	630 +130	+26%	+$36.1K	0.01%	309
2020 Q4	$125K	Hold	500	–	–	﹤0.01%	341
2020 Q3	$113K	Hold	500	–	–	﹤0.01%	326
2020 Q2	$85K	Sell	500 -15	-3%	-$2.39K	﹤0.01%	316
2020 Q1	$65K	Buy	+515	New	+$77.2K	﹤0.01%	356
2018 Q3	–	Sell	-500	Closed	-$56K	–	362
2018 Q2	$56K	Buy	+500	New	+$54.1K	﹤0.01%	393

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Washington Trust's CRL Position: Q2 2025 in Review

Washington Trust sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 528 shares — an estimated $79.5K sold.

Washington Trust first reported a position in CRL in Q2 2018 and held it in 22 quarters. The position peaked at $206K in Q3 2021. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

Washington Trust reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
Washington Trust sold 528 Charles River Laboratories shares in Q2 2025, an estimated $79.5K.
Washington Trust first reported a position in Charles River Laboratories in Q2 2018 and held it in 22 quarters.
Washington Trust's Charles River Laboratories position peaked at $206K in Q3 2021.
519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.